Sun Pharma to Dr. Reddy’s: Healthcare Stocks to Watch Ahead of Q4 Results, Cipla Among Systematix Top Picks

The quarter is likely to reflect mixed implications from the US-Iran conflict, as higher freight and raw material costs could partially offset the favorable impact of USD/Rs appreciation.